Bank of Nova Scotia
HQL

Bank of Nova Scotia’s abrdn Life Sciences Investors HQL Stock Holding History

Bank of Nova Scotia’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,019
Closed -$225K – 879
2018
Q3 		$225K Buy
+11,019
New +$219K ﹤0.01% 836
2017
Q3 		– Sell
-64,915
Closed -$1.35M – 960
2017
Q2 		$1.35M Buy
64,915
+4,479
+7% +$90.5K 0.01% 702
2017
Q1 		$1.17M Sell
60,436
-11,911
-16% -$221K 0.01% 732
2016
Q4 		$1.23M Sell
72,347
-16,465
-19% -$289K 0.01% 451
2016
Q3 		$1.66M Buy
88,812
+16,828
+23% +$317K 0.01% 334
2016
Q2 		$1.24M Buy
71,984
+5,849
+9% +$108K 0.01% 338
2016
Q1 		$1.19M Sell
66,135
-18,681
-22% -$339K 0.01% 343
2015
Q4 		$2M Buy
+84,816
New +$2.1M 0.01% 339

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Bank of Nova Scotia's HQL Position: Q4 2018 in Review

Bank of Nova Scotia sold out of abrdn Life Sciences Investors (HQL) in Q4 2018, closing a stake of 11,019 shares — an estimated $225K sold.

Bank of Nova Scotia first reported a position in HQL in Q4 2015 and held it in 8 quarters. The position peaked at $2M in Q4 2015. 59 funds tracked by Wall St. Rank hold HQL as of Q4 2018.

  • Bank of Nova Scotia reported no remaining abrdn Life Sciences Investors position as of Q4 2018 after selling out during the quarter.
  • Bank of Nova Scotia sold 11,019 abrdn Life Sciences Investors shares in Q4 2018, an estimated $225K.
  • Bank of Nova Scotia first reported a position in abrdn Life Sciences Investors in Q4 2015 and held it in 8 quarters.
  • Bank of Nova Scotia's abrdn Life Sciences Investors position peaked at $2M in Q4 2015.
  • 59 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2018.

Based on Bank of Nova Scotia's 13F filing for Q4 2018, filed 11 Feb 2019.